Literature DB >> 4355931

In vitro protein-synthesizing activity of vesicular stomatitis virus-infected cell extracts.

M J Grubman, D F Summers.   

Abstract

Crude cytoplasmic extracts from vesicular stomatitis virus (VSV)-infected HeLa cells incorporate radioactive amino acids into hot trichloroacetic acid-precipitable material linearly for 10 to 20 min. The material synthesized in vitro corresponds in molecular weight to four of the five VSV structural proteins. However, synthesis of the viral glycoprotein (G) is significantly reduced, whereas the relative amounts of viral structural proteins L and NS synthesized are increased compared with the ratio of the proteins found in the virion. Fractionation of a VSV-infected crude cytoplasmic extract into a cytoplasmic pellet (20,000 x g for 30 min) and a cytoplasmic supernatant results in a significant reduction in protein synthesizing activity of both fractions, although both contain polysomes. The products synthesized by a cytoplasmic supernatant-directed system included all the VSV structural proteins except the glycoprotein, whereas in an in vitro system directed by the cytoplasmic pellet there is a marked reduction in synthesis of the nucleoprotein (N) and also a small relative increase in synthesis of the glycoprotein. Addition of uninfected, preincubated HeLa or L-cell S10 or a HeLa ribosomal fraction to the VSV-infected cytoplasmic pellet results in a 30- to 60-fold stimulation of (35)S-methionine incorporation. However, these uninfected extracts do not stimulate (35)S-methionine incorporation by the infected crude cytoplasmic extract or the cytoplasmic supernatant. The products synthesized by the stimulated cytoplasmic pellet now include sizeable amounts of the glycoprotein in addition to the other VSV structural proteins.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4355931      PMCID: PMC356620     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Protein synthesis in vesicular stomatitis virus-infected HeLa cells.

Authors:  J A Mudd; D F Summers
Journal:  Virology       Date:  1970-10       Impact factor: 3.616

2.  Ribonucleic acid synthesis of vesicular stomatitis virus, II. An RNA polymerase in the virion.

Authors:  D Baltimore; A S Huang; M Stampfer
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

3.  The proteins of biologically active sub-units of vesicular stomatitis virus.

Authors:  B Cartwright; P Talbot; F Brown
Journal:  J Gen Virol       Date:  1970-06       Impact factor: 3.891

4.  Proteins of vesicular stomatitis virus. I. Polyacrylamide gel analysis of viral antigens.

Authors:  C Y Kang; L Prevec
Journal:  J Virol       Date:  1969-04       Impact factor: 5.103

5.  Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels.

Authors:  A L Shapiro; E Viñuela; J V Maizel
Journal:  Biochem Biophys Res Commun       Date:  1967-09-07       Impact factor: 3.575

6.  Subcellular site of glycoprotein synthesis in liver.

Authors:  J Molnar; M Tetas; H Chao
Journal:  Biochem Biophys Res Commun       Date:  1969-11-06       Impact factor: 3.575

7.  Protein composition of the structural components of vesicular stomatitis virus.

Authors:  R R Wagner; T C Schnaitman; R M Snyder; C A Schnaitman
Journal:  J Virol       Date:  1969-06       Impact factor: 5.103

8.  Comparison of membrane protein glycopeptides of Sindbis virus and vesicular stomatitis virus.

Authors:  B W Burge; A S Huang
Journal:  J Virol       Date:  1970-08       Impact factor: 5.103

9.  Proteins of vesicular stomatitis virus. II. Immunological comparisons of viral antigens.

Authors:  C Y Kang; L Prevec
Journal:  J Virol       Date:  1970-07       Impact factor: 5.103

10.  Proteins of vesicular stomatitis virus: kinetics and cellular sites of synthesis.

Authors:  R R Wagner; R M Snyder; S Yamazaki
Journal:  J Virol       Date:  1970-05       Impact factor: 5.103

View more
  14 in total

1.  Coupled in vitro transcription and translation of vesicular stomatitis virus messenger RNA.

Authors:  M Breindl; J J Holland
Journal:  Proc Natl Acad Sci U S A       Date:  1975-07       Impact factor: 11.205

2.  Oligosaccharide chains are trimmed during synthesis of the envelope glycoprotein of vesicular stomatitis virus.

Authors:  L A Hunt; J R Etchison; D F Summers
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

3.  Glycosylation sites of vesicular stomatitis virus glycoprotein.

Authors:  J S Robertson; J R Etchison; D F Summers
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

4.  Association of vesicular stomatitis virus proteins with HeLa cell membranes and released virus.

Authors:  L A Hunt; D F Summers
Journal:  J Virol       Date:  1976-12       Impact factor: 5.103

5.  Transcription and replication of vesicular stomatitis virus: effects of temperature-sensitive mutations in complementation group IV.

Authors:  A Combard; C Martinet; C Printz Ane; A Friedman; P Printz
Journal:  J Virol       Date:  1974-04       Impact factor: 5.103

6.  Oligosaccharide moieties of the glycoprotein of vesicular stomatitis virus.

Authors:  S A Moyer; J M Tsang; P H Atkinson; D F Summers
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

7.  Biochemical map of polypeptides specified by foot-and-mouth disease virus.

Authors:  M J Grubman; B H Robertson; D O Morgan; D M Moore; D Dowbenko
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

8.  In vitro translation with adenovirus polyribosomes.

Authors:  H Persson; B Oberg; L Philipson
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

9.  Phosphorylation of vesicular stomatitis virus in vivo and in vitro.

Authors:  S A Moyer; D F Summers
Journal:  J Virol       Date:  1974-02       Impact factor: 5.103

10.  Translation of vesicular stomatitis messenger RNA by extracts from mammalian and plant cells.

Authors:  T Morrison; M Stampfer; D Baltimore; H F Lodish
Journal:  J Virol       Date:  1974-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.